Swiss National Bank Sells 400 Shares of Encompass Health Co. (NYSE:EHC)

Swiss National Bank lessened its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 196,600 shares of the company’s stock after selling 400 shares during the period. Swiss National Bank’s holdings in Encompass Health were worth $18,999,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Harbor Capital Advisors Inc. increased its position in Encompass Health by 275.7% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock valued at $3,071,000 after acquiring an additional 26,270 shares in the last quarter. QRG Capital Management Inc. increased its holdings in shares of Encompass Health by 85.6% in the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock valued at $1,232,000 after purchasing an additional 6,627 shares in the last quarter. SG Americas Securities LLC bought a new position in Encompass Health in the 2nd quarter worth approximately $2,204,000. Los Angeles Capital Management LLC lifted its holdings in Encompass Health by 532.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after buying an additional 42,338 shares in the last quarter. Finally, Kennedy Capital Management LLC boosted its position in Encompass Health by 19.6% in the 1st quarter. Kennedy Capital Management LLC now owns 99,720 shares of the company’s stock valued at $8,235,000 after buying an additional 16,318 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Trading Up 0.1 %

EHC opened at $98.98 on Friday. Encompass Health Co. has a twelve month low of $63.78 and a twelve month high of $104.55. The firm has a market cap of $9.97 billion, a PE ratio of 23.91, a price-to-earnings-growth ratio of 1.31 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm’s fifty day moving average is $96.96 and its two-hundred day moving average is $90.69.

Encompass Health (NYSE:EHC) last posted its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the previous year, the company posted $0.86 earnings per share. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. Equities research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health’s payout ratio is 16.43%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on EHC. UBS Group upped their price target on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Stephens reaffirmed an “overweight” rating and issued a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. KeyCorp lifted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Barclays raised their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Royal Bank of Canada upped their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.